| Primary |
| Product Used For Unknown Indication |
67.2% |
| Hyperphosphataemia |
22.2% |
| Hyperparathyroidism Secondary |
2.8% |
| Hypertension |
1.5% |
| Constipation |
0.7% |
| Prophylaxis |
0.6% |
| Nephrogenic Anaemia |
0.5% |
| Cataract |
0.4% |
| Hyperuricaemia |
0.4% |
| Procedural Hypotension |
0.4% |
| Renal Impairment |
0.4% |
| Rhinitis Allergic |
0.4% |
| Insomnia |
0.4% |
| Arrhythmia |
0.3% |
| Diabetes Mellitus |
0.3% |
| Hyperkalaemia |
0.3% |
| Hyperlipidaemia |
0.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.3% |
| Thrombosis Prophylaxis |
0.3% |
| Gastritis |
0.2% |
|
| Nausea |
11.1% |
| Myocardial Infarction |
8.3% |
| Hypocalcaemia |
6.9% |
| Constipation |
5.6% |
| Hyperparathyroidism Secondary |
5.6% |
| Lung Neoplasm Malignant |
5.6% |
| Melaena |
5.6% |
| Vomiting |
5.6% |
| Diverticulitis |
4.2% |
| Gastric Ulcer |
4.2% |
| Gastroenteritis |
4.2% |
| Myocardial Ischaemia |
4.2% |
| Pancreatitis Acute |
4.2% |
| Pseudomembranous Colitis |
4.2% |
| Small Intestinal Perforation |
4.2% |
| Upper Respiratory Tract Inflammation |
4.2% |
| Visual Impairment |
4.2% |
| Acute Myocardial Infarction |
2.8% |
| Anaemia |
2.8% |
| Angina Pectoris |
2.8% |
|
| Secondary |
| Product Used For Unknown Indication |
68.3% |
| Hyperphosphataemia |
22.3% |
| Hyperparathyroidism Secondary |
2.6% |
| Constipation |
0.6% |
| Cataract |
0.5% |
| Hypertensive Heart Disease |
0.5% |
| Initial Insomnia |
0.5% |
| Productive Cough |
0.5% |
| Renal Impairment |
0.5% |
| Nephrogenic Anaemia |
0.5% |
| Arrhythmia |
0.4% |
| Prophylaxis |
0.4% |
| Renal Failure Chronic |
0.4% |
| Thrombosis Prophylaxis |
0.4% |
| Blood Pressure Decreased |
0.3% |
| Drug Use For Unknown Indication |
0.3% |
| Insomnia |
0.3% |
| Pollakiuria |
0.3% |
| Tinea Infection |
0.3% |
| Bone Pain |
0.2% |
|
| Hyperparathyroidism Secondary |
9.0% |
| Nausea |
9.0% |
| Upper Respiratory Tract Inflammation |
9.0% |
| Hypocalcaemia |
7.7% |
| Pseudomembranous Colitis |
7.7% |
| Small Intestinal Perforation |
7.7% |
| Cerebrovascular Accident |
5.1% |
| Peritonitis |
5.1% |
| Vomiting |
5.1% |
| Diarrhoea |
3.8% |
| Gastric Ulcer |
3.8% |
| Gastrointestinal Haemorrhage |
3.8% |
| Stress Fracture |
3.8% |
| Wrong Technique In Drug Usage Process |
3.8% |
| Acetonaemia |
2.6% |
| Acute Myocardial Infarction |
2.6% |
| Anaemia |
2.6% |
| Angina Pectoris |
2.6% |
| Cerebral Infarction |
2.6% |
| Condition Aggravated |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
42.2% |
| Drug Use For Unknown Indication |
23.1% |
| Nuclear Magnetic Resonance Imaging |
5.5% |
| Hypertension |
4.6% |
| Hyperphosphataemia |
3.3% |
| Nephrogenic Anaemia |
3.1% |
| Hyperparathyroidism Secondary |
3.0% |
| Anaemia |
1.7% |
| Peritoneal Dialysis |
1.5% |
| Renal Failure |
1.5% |
| Prophylaxis |
1.4% |
| Angiogram |
1.2% |
| Renal Failure Chronic |
1.2% |
| Pain |
1.1% |
| Dialysis |
1.0% |
| Infection |
1.0% |
| Haemodialysis |
0.9% |
| Cerebrovascular Disorder |
0.8% |
| Imaging Procedure |
0.8% |
| Renal Disorder |
0.8% |
|
| Vomiting |
9.7% |
| Hypocalcaemia |
8.3% |
| Therapeutic Response Decreased |
8.3% |
| General Physical Health Deterioration |
6.9% |
| Anaemia |
5.6% |
| Urosepsis |
5.6% |
| Wheezing |
5.6% |
| Calciphylaxis |
4.2% |
| Cerebral Ischaemia |
4.2% |
| Haematochezia |
4.2% |
| Haemorrhoids |
4.2% |
| Hypoglycaemia |
4.2% |
| Myocardial Infarction |
4.2% |
| Nausea |
4.2% |
| Renal Transplant |
4.2% |
| Skin Discolouration |
4.2% |
| Ventricular Fibrillation |
4.2% |
| Acute Left Ventricular Failure |
2.8% |
| Angina Pectoris |
2.8% |
| Blood Calcium Decreased |
2.8% |
|
